Patents by Inventor David S. Glenn

David S. Glenn has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240165215
    Abstract: The present disclosure relates to immunogenic compositions comprising at least one Yersinia pestis (Y. pestis) antigen, an aluminum salt adjuvant, and an oligonucleotide comprising an unmethylated cytidine-phospho-guanosine (CpG) motif. The immunogenic compositions are suitable for stimulating an immune response against Y. pestis in a subject in need thereof. The present disclosure also relates to kits and methods using the immunogenic compositions, or two separate compositions which together comprise the antigen, the aluminum salt adjuvant, and the oligonucleotide.
    Type: Application
    Filed: June 29, 2023
    Publication date: May 23, 2024
    Applicants: Dynavax Technologies Corporation, The Government of the United States, as Represented by the Secretary of the Army
    Inventors: Robert S. JANSSEN, David Novack, Wai Kwan Chung, Andrew M. Glenn, Lucy A. Ward
  • Publication number: 20090183069
    Abstract: Font/script association techniques are described. In an implementation, a client includes one or more modules to determine which of a plurality of scripts are to be used to display characters and one or more fonts are located that correspond to the determined script. Representations are output of the located one or more fonts in a user interface that are selectable to cause the characters to be displayed using a selected one of the fonts.
    Type: Application
    Filed: January 15, 2008
    Publication date: July 16, 2009
    Applicant: MICROSOFT CORPORATION
    Inventors: Finbarr S. Duggan, Anna M. Tholse, Mark R. Breivik, Michael J. Doyle, Rory A. Morrison, David S. Glenn, Peter G. Constable, Nicholas A. Beal, Mushegh Malkhasyan, Sebastien Molines